ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

0RAM Vistin Pharma Asa

11.25
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vistin Pharma Asa LSE:0RAM London Ordinary Share NO0010734122 VISTIN PHARMA ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.25 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 438.33M 45.64M 1.0293 10.93 498.88M

Management in Vistin Pharma ASA purchases shares

04/07/2023 7:30am

GlobeNewswire Inc.


Vistin Pharma Asa (LSE:0RAM)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more Vistin Pharma Asa Charts.
Management in Vistin Pharma ASA purchases shares

4 July 2023: Vistin Pharma ASA (the “Company”) has on 4 July 2023 sold shares to members of its management team for its long-term incentive plan (LTIP), as approved by the general meeting on the 22 May 2023, at a price of NOK 23,00 per share (the “Purchase Price”).

The following persons discharging managerial responsibilities (primary insiders) have purchased shares:

Kjell-Erik Nordby (CEO): 40 000 shares, each at a price equal to the Purchase PriceAfter this transaction, Kjell-Erik Nordby owns a total of 140 000 shares, corresponding to 0,32% of the share capital and voting rights

Alexander Karlsen (CFO): 50 000 shares, each at a price equal to the Purchase Price After this transaction, Alexander Karlsen owns a total of 50 000 shares, corresponding to 0,11% of the share capital and voting rights

Magnus Tolleshaug (CCO): 40 000 shares, each at a price equal to the Purchase Price After this transaction, Magnus Tolleshaug owns a total of 75 000 shares, corresponding to 0,17% of the share capital and voting rights

Vegard Heggem (VP Operations): 50 000 shares, each at a price equal to the Purchase PriceAfter this transaction, Vegard Heggem owns a total of 77 000 shares, corresponding to 0,17% of the share capital and voting rights

Hilde Merete Hagen (VP Quality): 40 000 shares, each at a price equal to the Purchase PriceAfter this transaction, Hilde Merete Hagen owns a total of 40 000 shares, corresponding to 0,09% of the share capital and voting rights

See attachments for further details.

After these transactions, the Company does not own any own shares.

This information is subject to disclosure requirements set out in the Market Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act Section 5-12.

Attachments

  • Notification of trade_skjema - Alexander Karlsen_LTIP
  • Notification of trade_skjema - Hilde Hagen_LTIP
  • Notification of trade_skjema - Kjell-Erik Nordby_LTIP
  • Notification of trade_skjema - Magnus Tolleshaug_LTIP
  • Notification of trade_skjema - Vegard Heggem_LTIP

1 Year Vistin Pharma Asa Chart

1 Year Vistin Pharma Asa Chart

1 Month Vistin Pharma Asa Chart

1 Month Vistin Pharma Asa Chart

Your Recent History

Delayed Upgrade Clock